Income StatementBalance SheetCash FlowSegments
Quest Diagnostics logo

Quest Diagnostics Cash Flow Statement

Operating, investing, and financing cash movements

Quest Diagnostics generated $1.9B in operating cash flow over the trailing twelve months. After $524.0M in capital expenditures, free cash flow was $1.3B. Free cash flow increased 0.3% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$1.9BNet Cash From Investing (TTM)-$668.0MNet Cash From Financing (TTM)-$979.0MCapital Expenditures (TTM)$524.0MDepreciation And Amortization Cf (TTM)$577.0MNet Change In Cash (TTM)-$286.0M
Latest FilingQ1 2026
Report Date2026-04-22
Market Cap$21.0B
P/E Ratio20.52
ROE14.33%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other non-cash income (expense)—$1.0M-$27.0M-$11.0M—-$8.0M
Other non-cash income (expense)—$1.0M-$27.0M-$11.0M—-$8.0M
Change in accounts payable—-$53.0M$42.0M$124.0M$16.0M-$12.0M
Change in accounts receivable—$101.0M$14.0M$38.0M—$180.0M
Change in income taxes payable/receivable—$15.0M—-$10.0M$25.0M$13.0M
Other working capital changes$56.0M-$49.0M-$33.0M——$31.0M
Deferred income taxes$34.0M$7.0M$1.0M$110.0M—$48.0M
Depreciation and amortization$135.0M$140.0M$143.0M$142.0M$145.0M$147.0M
Other Non-Cash Income (Expense)—$1.0M-$27.0M-$11.0M—-$8.0M
Other Non-cash Income (Expense)—$1.0M-$27.0M-$11.0M—-$8.0M
Other Non-cash Income (Expense)—$1.0M-$27.0M-$11.0M—-$8.0M
Net cash from operating activities$464.0M$314.0M$544.0M$563.0M$465.0M$278.0M
Net income$236.0M$235.0M$296.0M$259.0M$256.0M$264.0M
Other non-cash income (expense)—$1.0M-$27.0M-$11.0M—-$8.0M
Provision for credit losses$1.0M$1.0M$1.0M$0.0$1.0M$1.0M
Other Noncash Income (Expense)—$1.0M-$27.0M-$11.0M—-$8.0M
Other Non-cash Income and Expense—$1.0M-$27.0M-$11.0M—-$8.0M
Other Non-Cash Adjustments—$1.0M-$27.0M-$11.0M—-$8.0M
Other Non-Cash Income and Expense—$1.0M-$27.0M-$11.0M—-$8.0M
Stock-based compensation$27.0M$22.0M$21.0M$20.0M$25.0M$20.0M

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired$383.0M$0.0$17.0M$34.0M$50.0M$38.0M
Capital expenditures$123.0M$117.0M$108.0M$144.0M$158.0M$114.0M
Payment for (Proceeds from) Other Investing Activity-$4.0M-$2.0M-$1.0M$23.0M—$0.0
Net cash from investing activities-$502.0M-$115.0M-$124.0M-$201.0M-$191.0M-$152.0M
Other investing activities-$4.0M-$2.0M-$1.0M$23.0M—$0.0

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Proceeds from issuance of debt$0.0$215.0M$185.0M$10.0M$0.0$0.0
Repayments of debt$1.0M$600.0M$401.0M$10.0M$1.0M$1.0M
Distributions to noncontrolling interests$12.0M$18.0M$11.0M$14.0M$13.0M$7.0M
Dividends paid$84.0M$84.0M$90.0M$89.0M$90.0M$88.0M
Proceeds from issuances of debt$0.0$215.0M$185.0M$10.0M$0.0$0.0
Other, net$57.0M-$61.0M$11.0M-$11.0M$100.0M-$84.0M
Repayments of Debt$1.0M$600.0M$401.0M$10.0M$1.0M$1.0M
Payment of Deferred Purchase Consideration$57.0M-$61.0M$11.0M-$11.0M$100.0M-$84.0M
Noncontrolling interest transactions and other$57.0M-$61.0M$11.0M-$11.0M$100.0M-$84.0M
Net cash from financing activities—-$561.0M-$293.0M-$247.0M-$287.0M-$152.0M
Other financing activities$57.0M-$61.0M$11.0M-$11.0M$100.0M-$84.0M
Noncontrolling Interests Activity and Other$57.0M-$61.0M$11.0M-$11.0M$100.0M-$84.0M
Proceeds from issuance of common stock$21.0M$29.0M$13.0M$19.0M$18.0M$65.0M
Taxes paid for net share settlement—$42.0M$0.0$2.0M$1.0M$37.0M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$341.0M$197.0M$436.0M$419.0M$307.0M$164.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$7.0M$1.0M$4.0M—$1.0M-$1.0M
Net increase (decrease) in cash-$215.0M-$361.0M——-$12.0M-$27.0M